Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
256,606,920
-
Total 13F shares
-
240,735,835
-
Share change
-
+4,307,896
-
Total reported value
-
$107,165,642,790
-
Put/Call ratio
-
57%
-
Price per share
-
$445.20
-
Number of holders
-
1,543
-
Value change
-
+$1,856,744,900
-
Number of buys
-
709
-
Number of sells
-
754
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q2 2025
As of 30 Jun 2025 VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) had 1,543 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 240,735,835 shares of stock of the company.
Largest 10 holders included Capital World Investors, VANGUARD GROUP INC, BlackRock, Inc., Capital Research Global Investors, STATE STREET CORP, FMR LLC, JENNISON ASSOCIATES LLC, GEODE CAPITAL MANAGEMENT, LLC, JPMORGAN CHASE & CO, and WELLINGTON MANAGEMENT GROUP LLP.
This table shows 1,545 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.